Article info

Original research
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Authors

  1. Correspondence to Dr Shahneen Sandhu; Shahneen.Sandhu{at}petermac.org
View Full Text

Citation

Weppler AM, Pattison A, Bhave P, et al
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Publication history

  • Accepted August 25, 2020
  • First published October 15, 2020.
Online issue publication 
October 15, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.